This co-sponsored program will explore current issues in public health and medicine as connected to innovations in the life sciences. Topics include FDA regulatory approaches to off-label drug risks, potential liability of clinical genetics laboratories based on medical malpractice theory, and health information regulation under the Twenty-First Century Cures Act.
Papers from this program will be published in the Annals of Health Law & Life Sciences.